A Competing Risks Model with Time Varying Covariates for Estimation of Breast Cancer Risks in BRCA1 Families
暂无分享,去创建一个
J. Hopper | E. John | S. Buys | I. Andrulis | L. Briollais | M. Daly | M. Terry | Yun-Hee Choi | Hae Jung | Fodé Tounkara | Fode Tounkara
[1] Jacques Simard,et al. Sequence kernel association test for survival outcomes in the presence of a non-susceptible fraction. , 2020, Biostatistics.
[2] H. Jacqmin-Gadda,et al. Joint nested frailty models for clustered recurrent and terminal events: An application to colonoscopy screening visits and colorectal cancer risks in Lynch Syndrome families , 2020, Statistical methods in medical research.
[3] W. Chung,et al. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk , 2018, Journal of the National Cancer Institute.
[4] J. Horrocks,et al. Exponential decay for binary time‐varying covariates in Cox models , 2018, Statistics in medicine.
[5] W. Chung,et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.
[6] W. Chung,et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers , 2017, Journal of the National Cancer Institute.
[7] Aung Ko Win,et al. Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas , 2017, Biometrics.
[8] A. Whittemore,et al. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) , 2015, International journal of epidemiology.
[9] A. Green,et al. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer. , 2015, Surgical oncology.
[10] M. Pollán,et al. Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis. , 2014, Breast.
[11] G. Parmigiani,et al. Recent BRCAPRO Upgrades Significantly Improve Calibration , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[12] G. Parmigiani,et al. Calibrated predictions for multivariate competing risks models , 2014, Lifetime data analysis.
[13] D. Easton,et al. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface , 2013, British Journal of Cancer.
[14] Malka Gorfine,et al. Frailty‐Based Competing Risks Model for Multivariate Survival Data , 2011, Biometrics.
[15] A. Wienke. Frailty Models in Survival Analysis , 2010 .
[16] G. Feldman,et al. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 , 2010, Genetics in Medicine.
[17] Per Kragh Andersen,et al. Competing Risks and Time‐Dependent Covariates , 2009, Biometrical journal. Biometrische Zeitschrift.
[18] L. Briollais,et al. Estimating Disease Risk Associated with Mutated Genes in Family-Based Designs , 2008, Human Heredity.
[19] Giovanni Parmigiani,et al. Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Norman Boyd,et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.
[21] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.
[22] L. Cannon-Albright,et al. Risk modifiers in carriers of brca1 mutations , 1995, International journal of cancer.
[23] N Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.
[24] D. Cox,et al. Analysis of Survival Data. , 1985 .
[25] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[26] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[27] Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. , 2017, Obstetrics and gynecology.
[28] A. Yashin,et al. Genetic analysis of durations: Correlated frailty model applied to survival of Danish twins , 1995, Genetic epidemiology.